TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors
Clinical trial NCT05650580 · UNKNOWN
Trial details
- NCT number
- NCT05650580
- Sponsor
- Tarapeutics Science Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-23
- Primary completion
- 2025-07-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.